Advances In Eyecare

The lowering of intraocular pressure (IOP) is the mainstay treatment for primary open angle-glaucoma and slows down further progression of the disease. Many patients present with raised IOP but without optic nerve damage and this is termed ocular hypertension. Many ocular hypertensives convert to glaucoma, and so lowering their IOP helps reduce the risk of the disease establishing. Recently published LiGHT study suggests that the use of a laser treatment, selective laser trabeculoplasty (SLT), may replace the need for on-going use of IOP-lowering drops. In this interview, we speak to Dr Deacon Harle and Patrick Gunn to find out more about the SLT technique, and what it means for optometrists.